00002004061/32020Q2FALSE3342261.001.004,320,0004,320,0003,119,8433,119,843487,466487,336114681064415511134351024616391.011.960.951.851.12.23.5502.4500.2502.2506.7303.3752.0500.6505.5002.6252.4502.952.9001.1506.9504.9504.3751.6503.5505.9503.6253.4005.8504.5004.8504.5003.7003.753.503 months, 21 days00002004062019-12-302020-06-280000200406us-gaap:CommonStockMember2019-12-302020-06-280000200406jnj:A0.250NotesDue2022Member2019-12-302020-06-280000200406jnj:A0.650NotesDue2024Member2019-12-302020-06-280000200406jnj:A5.50NotesDue2024Member2019-12-302020-06-280000200406jnj:A1.150NotesDue2028Member2019-12-302020-06-280000200406jnj:A1.650NotesDue2035Member2019-12-302020-06-28xbrli:shares00002004062020-07-20iso4217:USD00002004062020-06-2800002004062019-12-29iso4217:USDxbrli:shares00002004062020-03-302020-06-28xbrli:pure00002004062019-04-012019-06-3000002004062018-12-312019-06-3000002004062020-03-290000200406us-gaap:RetainedEarningsMember2020-03-290000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-290000200406us-gaap:CommonStockMember2020-03-290000200406us-gaap:TreasuryStockMember2020-03-290000200406us-gaap:RetainedEarningsMember2020-03-302020-06-280000200406us-gaap:TreasuryStockMember2020-03-302020-06-280000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-302020-06-280000200406us-gaap:RetainedEarningsMember2020-06-280000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-280000200406us-gaap:CommonStockMember2020-06-280000200406us-gaap:TreasuryStockMember2020-06-280000200406us-gaap:RetainedEarningsMember2019-12-290000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-290000200406us-gaap:CommonStockMember2019-12-290000200406us-gaap:TreasuryStockMember2019-12-290000200406us-gaap:RetainedEarningsMember2019-12-302020-06-280000200406us-gaap:TreasuryStockMember2019-12-302020-06-280000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-302020-06-2800002004062019-03-310000200406us-gaap:RetainedEarningsMember2019-03-310000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310000200406us-gaap:CommonStockMember2019-03-310000200406us-gaap:TreasuryStockMember2019-03-310000200406us-gaap:RetainedEarningsMember2019-04-012019-06-300000200406us-gaap:TreasuryStockMember2019-04-012019-06-300000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-3000002004062019-06-300000200406us-gaap:RetainedEarningsMember2019-06-300000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300000200406us-gaap:CommonStockMember2019-06-300000200406us-gaap:TreasuryStockMember2019-06-3000002004062018-12-300000200406us-gaap:RetainedEarningsMember2018-12-300000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-300000200406us-gaap:CommonStockMember2018-12-300000200406us-gaap:TreasuryStockMember2018-12-300000200406us-gaap:RetainedEarningsMember2018-12-312019-06-300000200406us-gaap:TreasuryStockMember2018-12-312019-06-300000200406us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-312019-06-3000002004062019-12-302020-03-290000200406jnj:PatentsAndTrademarksMember2020-06-280000200406jnj:PatentsAndTrademarksMember2019-12-290000200406us-gaap:OtherIntangibleAssetsMember2020-06-280000200406us-gaap:OtherIntangibleAssetsMember2019-12-290000200406us-gaap:TrademarksMember2020-06-280000200406us-gaap:TrademarksMember2019-12-290000200406jnj:PurchasedInProcessResearchAndDevelopmentMember2020-06-280000200406jnj:PurchasedInProcessResearchAndDevelopmentMember2019-12-290000200406jnj:BermekimabMemberjnj:PurchasedInProcessResearchAndDevelopmentMember2020-03-290000200406jnj:PurchasedInProcessResearchAndDevelopmentMemberjnj:VerbSurgicalInc.Member2020-03-290000200406jnj:ConsumerMember2019-12-290000200406jnj:PharmaceuticalMember2019-12-290000200406jnj:MedicalDevicesMember2019-12-290000200406jnj:ConsumerMember2019-12-302020-06-280000200406jnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:ConsumerMember2020-06-280000200406jnj:PharmaceuticalMember2020-06-280000200406jnj:MedicalDevicesMember2020-06-280000200406jnj:PatentsAndTrademarksMember2019-12-302020-06-280000200406us-gaap:OtherIntangibleAssetsMember2019-12-302020-06-280000200406us-gaap:ForeignExchangeContractMember2020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMember2020-06-280000200406us-gaap:ForeignExchangeContractMember2019-12-290000200406us-gaap:CrossCurrencyInterestRateContractMember2019-12-290000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:SalesMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberjnj:InterestIncomeExpenseNetMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:FairValueHedgingMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:SalesMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberjnj:InterestIncomeExpenseNetMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:FairValueHedgingMember2019-04-012019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2020-03-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2020-03-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-03-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2020-03-302020-06-280000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-03-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2019-04-012019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2019-04-012019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-04-012019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2019-04-012019-06-300000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:CashFlowHedgingMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:CashFlowHedgingMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:SalesMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberjnj:InterestIncomeExpenseNetMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:FairValueHedgingMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:SalesMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueHedgingMemberjnj:InterestIncomeExpenseNetMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:FairValueHedgingMember2018-12-312019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2019-12-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2019-12-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-12-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2019-12-302020-06-280000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-12-302020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2018-12-312019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2018-12-312019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2018-12-312019-06-300000200406us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2018-12-312019-06-300000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:CashFlowHedgingMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:ResearchAndDevelopmentExpenseMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberjnj:InterestIncomeExpenseNetMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMemberjnj:OtherIncomeExpenseNetMemberus-gaap:CashFlowHedgingMember2018-12-312019-06-300000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2020-03-302020-06-280000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2019-04-012019-06-300000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2019-12-302020-06-280000200406jnj:OtherIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2018-12-312019-06-300000200406us-gaap:SaleOfSubsidiaryGainLossMember2020-03-302020-06-280000200406us-gaap:SaleOfSubsidiaryGainLossMember2019-04-012019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMember2020-03-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMember2019-04-012019-06-300000200406jnj:OtherIncomeExpenseNetMember2020-03-302020-06-280000200406jnj:OtherIncomeExpenseNetMember2019-04-012019-06-300000200406us-gaap:SaleOfSubsidiaryGainLossMember2019-12-302020-06-280000200406us-gaap:SaleOfSubsidiaryGainLossMember2018-12-312019-06-300000200406us-gaap:CrossCurrencyInterestRateContractMember2019-12-302020-06-280000200406us-gaap:CrossCurrencyInterestRateContractMember2018-12-312019-06-300000200406jnj:OtherIncomeExpenseNetMember2019-12-302020-06-280000200406jnj:OtherIncomeExpenseNetMember2018-12-312019-06-300000200406jnj:EquityInvestmentswithReadilyDeterminableValueMemberus-gaap:EquitySecuritiesMember2019-12-290000200406jnj:EquityInvestmentswithReadilyDeterminableValueMemberus-gaap:EquitySecuritiesMember2019-12-302020-06-280000200406jnj:EquityInvestmentswithReadilyDeterminableValueMemberus-gaap:EquitySecuritiesMember2020-06-280000200406jnj:EquityInvestmentswithoutReadilyDeterminableValueMemberus-gaap:EquitySecuritiesMember2019-12-290000200406jnj:EquityInvestmentswithoutReadilyDeterminableValueMemberus-gaap:EquitySecuritiesMember2019-12-302020-06-280000200406jnj:EquityInvestmentswithoutReadilyDeterminableValueMemberus-gaap:EquitySecuritiesMember2020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Member2020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2020-06-280000200406us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2019-12-290000200406us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateContractMember2020-06-280000200406us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMember2020-06-280000200406us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateContractMember2020-06-280000200406us-gaap:InterestRateContractMember2020-06-280000200406us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMember2019-12-290000200406us-gaap:FairValueInputsLevel1Member2020-06-280000200406us-gaap:FairValueInputsLevel2Member2020-06-280000200406us-gaap:FairValueInputsLevel3Member2020-06-280000200406us-gaap:FairValueInputsLevel2Member2019-12-290000200406us-gaap:FairValueInputsLevel1Member2019-12-290000200406us-gaap:FairValueInputsLevel3Member2019-12-290000200406us-gaap:InterestRateContractMember2019-12-290000200406us-gaap:OtherNoncurrentLiabilitiesMemberjnj:AurisHealthMember2020-06-280000200406us-gaap:OtherNoncurrentLiabilitiesMemberjnj:AurisHealthMember2019-12-290000200406us-gaap:OtherCurrentLiabilitiesMember2020-06-280000200406us-gaap:OtherCurrentLiabilitiesMember2019-12-290000200406jnj:AurisHealthMember2019-12-302020-06-280000200406us-gaap:OtherNoncurrentLiabilitiesMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberus-gaap:CashMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberus-gaap:SovereignDebtSecuritiesMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberus-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberjnj:OtherReverseRepurchaseAgreementsMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberus-gaap:CorporateDebtSecuritiesMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberus-gaap:MoneyMarketFundsMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMemberus-gaap:BankTimeDepositsMember2020-06-280000200406us-gaap:HeldtomaturitySecuritiesMember2020-06-280000200406us-gaap:USTreasuryAndGovernmentMemberus-gaap:AvailableforsaleSecuritiesMember2020-06-280000200406us-gaap:AvailableforsaleSecuritiesMemberus-gaap:CorporateDebtSecuritiesMember2020-06-280000200406us-gaap:AvailableforsaleSecuritiesMember2020-06-280000200406us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A2.45Notesdue2021Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMemberjnj:A2.45Notesdue2021Member2020-06-280000200406jnj:A0.250NotesDue2022Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A0.250NotesDue2022Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A2.25Notesdue2022Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A2.25Notesdue2022Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A6.73Debenturesdue2023Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A6.73Debenturesdue2023Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.375Notesdue2023Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A3.375Notesdue2023Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A2.05Notesdue2023Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A2.05Notesdue2023Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A0.650NotesDue2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A0.650NotesDue2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A5.50NotesDue2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMemberjnj:A5.50NotesDue2024Member2020-06-280000200406jnj:A2.625Notesdue2025Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A2.625Notesdue2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A2.45Notesdue2026Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A2.45Notesdue2026Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A2.95Notesdue2027Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A2.95Notesdue2027Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A2.900Notesdue2028Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMemberjnj:A2.900Notesdue2028Member2020-06-280000200406jnj:A1.150NotesDue2028Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMemberjnj:A1.150NotesDue2028Member2020-06-280000200406jnj:A6.95Notesdue2029Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A6.95Notesdue2029Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A4.95Debenturesdue2033Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMemberjnj:A4.95Debenturesdue2033Member2020-06-280000200406jnj:A4.375Notesdue2033Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A4.375Notesdue2033Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A1.650NotesDue2035Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A1.650NotesDue2035Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.55Notesdue2036Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406us-gaap:EstimateOfFairValueFairValueDisclosureMemberjnj:A3.55Notesdue2036Member2020-06-280000200406jnj:A5.95Notesdue2037Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A5.95Notesdue2037Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.625Notesdue2037Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A3.625Notesdue2037Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.400Notesdue2038Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A3.400Notesdue2038Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A5.85Debenturesdue2038Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A5.85Debenturesdue2038Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A4.50Debenturesdue2040Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A4.50Debenturesdue2040Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A4.85Notesdue2041Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A4.85Notesdue2041Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A4.50Notesdue2043Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A4.50Notesdue2043Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.70Notesdue2046Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A3.70Notesdue2046Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.75Notesdue2047Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A3.75Notesdue2047Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:A3.500Notesdue2048Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:A3.500Notesdue2048Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-280000200406jnj:NotesDuePeriodFifteenMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-280000200406jnj:NotesDuePeriodFifteenMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-2800002004062018-12-312019-12-290000200406us-gaap:CommercialPaperMember2020-06-280000200406jnj:A3.55Notesdue2021Member2020-06-280000200406jnj:A2.45Notesdue2021Member2020-06-280000200406jnj:A0.250NotesDue2022Member2020-06-280000200406jnj:A2.25Notesdue2022Member2020-06-280000200406jnj:A6.73Debenturesdue2023Member2020-06-280000200406jnj:A3.375Notesdue2023Member2020-06-280000200406jnj:A2.05Notesdue2023Member2020-06-280000200406jnj:A0.650NotesDue2024Member2020-06-280000200406jnj:A5.50NotesDue2024Member2020-06-280000200406jnj:A2.625Notesdue2025Member2020-06-280000200406jnj:A2.45Notesdue2026Member2020-06-280000200406jnj:A2.95Notesdue2027Member2020-06-280000200406jnj:A2.900Notesdue2028Member2020-06-280000200406jnj:A1.150NotesDue2028Member2020-06-280000200406jnj:A6.95Notesdue2029Member2020-06-280000200406jnj:A4.95Debenturesdue2033Member2020-06-280000200406jnj:A4.375Notesdue2033Member2020-06-280000200406jnj:A1.650NotesDue2035Member2020-06-280000200406jnj:A3.55Notesdue2036Member2020-06-280000200406jnj:A5.95Notesdue2037Member2020-06-280000200406jnj:A3.625Notesdue2037Member2020-06-280000200406jnj:A3.400Notesdue2038Member2020-06-280000200406jnj:A5.85Debenturesdue2038Member2020-06-280000200406jnj:A4.50Debenturesdue2040Member2020-06-280000200406jnj:A4.85Notesdue2041Member2020-06-280000200406jnj:A4.50Notesdue2043Member2020-06-280000200406jnj:A3.70Notesdue2046Member2020-06-280000200406jnj:A3.75Notesdue2047Member2020-06-280000200406jnj:A3.500Notesdue2048Member2020-06-280000200406us-gaap:CommercialPaperMember2019-12-302020-06-280000200406jnj:AccruedTaxesOnIncomeMember2020-06-280000200406us-gaap:InternalRevenueServiceIRSMember2020-03-302020-06-280000200406us-gaap:PensionPlansDefinedBenefitMember2020-03-302020-06-280000200406us-gaap:PensionPlansDefinedBenefitMember2019-04-012019-06-300000200406us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-03-302020-06-280000200406us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-04-012019-06-300000200406us-gaap:PensionPlansDefinedBenefitMember2019-12-302020-06-280000200406us-gaap:PensionPlansDefinedBenefitMember2018-12-312019-06-300000200406us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-302020-06-280000200406us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-12-312019-06-300000200406country:US2019-12-302020-06-280000200406us-gaap:ForeignPlanMember2019-12-302020-06-280000200406us-gaap:AccumulatedTranslationAdjustmentMember2019-12-290000200406us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-290000200406us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-290000200406us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-290000200406us-gaap:AccumulatedTranslationAdjustmentMember2019-12-302020-06-280000200406us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-302020-06-280000200406us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-302020-06-280000200406us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-302020-06-280000200406us-gaap:AccumulatedTranslationAdjustmentMember2020-06-280000200406us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-280000200406us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-280000200406us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-06-280000200406jnj:BabyCareMembercountry:USjnj:ConsumerMember2020-03-302020-06-280000200406jnj:BabyCareMembercountry:USjnj:ConsumerMember2019-04-012019-06-300000200406jnj:BabyCareMembercountry:USjnj:ConsumerMember2019-12-302020-06-280000200406jnj:BabyCareMembercountry:USjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:BabyCareMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:BabyCareMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:BabyCareMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:BabyCareMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:BabyCareMemberjnj:ConsumerMember2020-03-302020-06-280000200406jnj:BabyCareMemberjnj:ConsumerMember2019-04-012019-06-300000200406jnj:BabyCareMemberjnj:ConsumerMember2019-12-302020-06-280000200406jnj:BabyCareMemberjnj:ConsumerMember2018-12-312019-06-300000200406country:USjnj:BeautyMemberjnj:ConsumerMember2020-03-302020-06-280000200406country:USjnj:BeautyMemberjnj:ConsumerMember2019-04-012019-06-300000200406country:USjnj:BeautyMemberjnj:ConsumerMember2019-12-302020-06-280000200406country:USjnj:BeautyMemberjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:BeautyMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:BeautyMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:BeautyMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:BeautyMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:BeautyMemberjnj:ConsumerMember2020-03-302020-06-280000200406jnj:BeautyMemberjnj:ConsumerMember2019-04-012019-06-300000200406jnj:BeautyMemberjnj:ConsumerMember2019-12-302020-06-280000200406jnj:BeautyMemberjnj:ConsumerMember2018-12-312019-06-300000200406country:USjnj:OralCareMemberjnj:ConsumerMember2020-03-302020-06-280000200406country:USjnj:OralCareMemberjnj:ConsumerMember2019-04-012019-06-300000200406country:USjnj:OralCareMemberjnj:ConsumerMember2019-12-302020-06-280000200406country:USjnj:OralCareMemberjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OralCareMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OralCareMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OralCareMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OralCareMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:OralCareMemberjnj:ConsumerMember2020-03-302020-06-280000200406jnj:OralCareMemberjnj:ConsumerMember2019-04-012019-06-300000200406jnj:OralCareMemberjnj:ConsumerMember2019-12-302020-06-280000200406jnj:OralCareMemberjnj:ConsumerMember2018-12-312019-06-300000200406country:USjnj:OTCMemberjnj:ConsumerMember2020-03-302020-06-280000200406country:USjnj:OTCMemberjnj:ConsumerMember2019-04-012019-06-300000200406country:USjnj:OTCMemberjnj:ConsumerMember2019-12-302020-06-280000200406country:USjnj:OTCMemberjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OTCMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OTCMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OTCMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OTCMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:OTCMemberjnj:ConsumerMember2020-03-302020-06-280000200406jnj:OTCMemberjnj:ConsumerMember2019-04-012019-06-300000200406jnj:OTCMemberjnj:ConsumerMember2019-12-302020-06-280000200406jnj:OTCMemberjnj:ConsumerMember2018-12-312019-06-300000200406country:USjnj:WomensHealthMemberjnj:ConsumerMember2020-03-302020-06-280000200406country:USjnj:WomensHealthMemberjnj:ConsumerMember2019-04-012019-06-300000200406country:USjnj:WomensHealthMemberjnj:ConsumerMember2019-12-302020-06-280000200406country:USjnj:WomensHealthMemberjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:WomensHealthMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:WomensHealthMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:WomensHealthMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:WomensHealthMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:WomensHealthMemberjnj:ConsumerMember2020-03-302020-06-280000200406jnj:WomensHealthMemberjnj:ConsumerMember2019-04-012019-06-300000200406jnj:WomensHealthMemberjnj:ConsumerMember2019-12-302020-06-280000200406jnj:WomensHealthMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:WoundCareandOtherMembercountry:USjnj:ConsumerMember2020-03-302020-06-280000200406jnj:WoundCareandOtherMembercountry:USjnj:ConsumerMember2019-04-012019-06-300000200406jnj:WoundCareandOtherMembercountry:USjnj:ConsumerMember2019-12-302020-06-280000200406jnj:WoundCareandOtherMembercountry:USjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:WoundCareandOtherMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:WoundCareandOtherMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:WoundCareandOtherMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:WoundCareandOtherMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:WoundCareandOtherMemberjnj:ConsumerMember2020-03-302020-06-280000200406jnj:WoundCareandOtherMemberjnj:ConsumerMember2019-04-012019-06-300000200406jnj:WoundCareandOtherMemberjnj:ConsumerMember2019-12-302020-06-280000200406jnj:WoundCareandOtherMemberjnj:ConsumerMember2018-12-312019-06-300000200406country:USjnj:ConsumerMember2020-03-302020-06-280000200406country:USjnj:ConsumerMember2019-04-012019-06-300000200406country:USjnj:ConsumerMember2019-12-302020-06-280000200406country:USjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:ConsumerMember2018-12-312019-06-300000200406jnj:ConsumerMember2020-03-302020-06-280000200406jnj:ConsumerMember2019-04-012019-06-300000200406jnj:ConsumerMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:ImmunologyMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:ImmunologyMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:ImmunologyMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:ImmunologyMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:RemicadeMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:RemicadeMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:RemicadeMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:RemicadeMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:RemicadeMemberjnj:UNITEDSTATESExportsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:RemicadeMemberjnj:UNITEDSTATESExportsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:RemicadeMemberjnj:UNITEDSTATESExportsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:RemicadeMemberjnj:UNITEDSTATESExportsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:RemicadeMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:RemicadeMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:RemicadeMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:RemicadeMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:RemicadeMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:RemicadeMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:RemicadeMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:RemicadeMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:SimponiSimponiAriaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:SimponiSimponiAriaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:SimponiSimponiAriaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:SimponiSimponiAriaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:SimponiSimponiAriaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:SimponiSimponiAriaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:SimponiSimponiAriaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:SimponiSimponiAriaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:SimponiSimponiAriaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:SimponiSimponiAriaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:SimponiSimponiAriaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:SimponiSimponiAriaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406country:USjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406country:USjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406country:USjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406country:USjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:StelaraMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:TremfyaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:TremfyaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:TremfyaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:TremfyaMembercountry:USjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:TremfyaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:TremfyaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:TremfyaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:TremfyaMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:TremfyaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:TremfyaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:TremfyaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:TremfyaMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406country:USjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406country:USjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406country:USjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406country:USjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406jnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2020-03-302020-06-280000200406jnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-04-012019-06-300000200406jnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2019-12-302020-06-280000200406jnj:OtherImmunologyMemberjnj:PharmaceuticalMemberjnj:ImmunologyMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406jnj:InfectiousDiseasesMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:InfectiousDiseasesMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:InfectiousDiseasesMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:InfectiousDiseasesMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:InfectiousDiseasesMemberjnj:EDURANTrilpivirineMember2018-12-312019-06-300000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMembercountry:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMembercountry:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMembercountry:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMembercountry:USjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406country:USjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406country:USjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406country:USjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406country:USjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406jnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2020-03-302020-06-280000200406jnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-04-012019-06-300000200406jnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2019-12-302020-06-280000200406jnj:OtherInfectiousDiseasesMemberjnj:PharmaceuticalMemberjnj:InfectiousDiseasesMember2018-12-312019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:NeuroscienceMemberjnj:CONCERTAMethylphenidateMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:NeuroscienceMemberjnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2020-03-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2019-04-012019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2019-12-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2018-12-312019-06-300000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2020-03-302020-06-280000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2019-04-012019-06-300000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2019-12-302020-06-280000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:RISPERDALCONSTAMember2018-12-312019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2020-03-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2019-04-012019-06-300000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2019-12-302020-06-280000200406jnj:NeuroscienceMembercountry:USjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2018-12-312019-06-300000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2020-03-302020-06-280000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2019-04-012019-06-300000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2019-12-302020-06-280000200406jnj:NeuroscienceMemberjnj:PharmaceuticalMemberjnj:OTHERNEUROSCIENCEMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:DARZALEXMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:DARZALEXMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:DARZALEXMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:DARZALEXMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:DARZALEXMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:ERLEADAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:ERLEADAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:ERLEADAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:ERLEADAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:ERLEADAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:IMBRUVICAMember2018-12-312019-06-300000200406country:USjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406country:USjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406country:USjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406country:USjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:VELCADEMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:ZYTIGAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:ZYTIGAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:ZYTIGAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:ZYTIGAMembercountry:USjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:ZYTIGAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:ZYTIGAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:ZYTIGAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:ZYTIGAMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406jnj:ZYTIGAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2020-03-302020-06-280000200406jnj:ZYTIGAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-04-012019-06-300000200406jnj:ZYTIGAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2019-12-302020-06-280000200406jnj:ZYTIGAMemberjnj:PharmaceuticalMemberjnj:OncologyMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:OncologyMemberjnj:OtherOncologyMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:OPSUMITMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2018-12-312019-06-300000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2020-03-302020-06-280000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2019-04-012019-06-300000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2019-12-302020-06-280000200406jnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMemberjnj:UPTRAVIMember2018-12-312019-06-300000200406jnj:OtherMembercountry:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2020-03-302020-06-280000200406jnj:OtherMembercountry:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-04-012019-06-300000200406jnj:OtherMembercountry:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-12-302020-06-280000200406jnj:OtherMembercountry:USjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2018-12-312019-06-300000200406jnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2020-03-302020-06-280000200406jnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-04-012019-06-300000200406jnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2019-12-302020-06-280000200406jnj:OtherMemberjnj:PharmaceuticalMemberjnj:PulmonaryHypertensionMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:XareltoMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:XareltoMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:XareltoMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:XareltoMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:XareltoMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:XareltoMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:XareltoMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:XareltoMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:XareltoMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:XareltoMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:XareltoMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:XareltoMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:INVOKANAINVOKAMETMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMembercountry:USjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:PharmaceuticalMemberjnj:PROCRITEPREXMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMembercountry:USjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMembercountry:USjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMembercountry:USjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMembercountry:USjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberus-gaap:NonUsMemberjnj:OtherMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406jnj:CardiovascularMetabolismOtherMemberjnj:OtherMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406country:USjnj:PharmaceuticalMember2020-03-302020-06-280000200406country:USjnj:PharmaceuticalMember2019-04-012019-06-300000200406country:USjnj:PharmaceuticalMember2019-12-302020-06-280000200406country:USjnj:PharmaceuticalMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406jnj:PharmaceuticalMember2020-03-302020-06-280000200406jnj:PharmaceuticalMember2019-04-012019-06-300000200406jnj:PharmaceuticalMember2018-12-312019-06-300000200406country:USjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:InterventionalSolutionsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:HIPSMembercountry:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:HIPSMembercountry:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:HIPSMembercountry:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:HIPSMembercountry:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:HIPSMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:OrthopaedicsMemberjnj:KNEESMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:OrthopaedicsMemberjnj:TRAUMAMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2020-03-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2019-04-012019-06-300000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2019-12-302020-06-280000200406country:USjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2018-12-312019-06-300000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2020-03-302020-06-280000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2019-04-012019-06-300000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2019-12-302020-06-280000200406jnj:OrthopaedicsMemberjnj:MedicalDevicesMemberjnj:SPINEOTHERMember2018-12-312019-06-300000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMember2020-03-302020-06-280000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMember2019-04-012019-06-300000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMember2019-12-302020-06-280000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2018-12-312019-06-300000200406jnj:SurgeryMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:SurgeryMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:SurgeryMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:SurgeryMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2020-03-302020-06-280000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2019-04-012019-06-300000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2019-12-302020-06-280000200406country:USjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2018-12-312019-06-300000200406jnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2020-03-302020-06-280000200406jnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2019-04-012019-06-300000200406jnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2019-12-302020-06-280000200406jnj:MedicalDevicesMemberjnj:SurgeryMemberjnj:ADVANCEDMember2018-12-312019-06-300000200406country:USjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2020-03-302020-06-280000200406country:USjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-04-012019-06-300000200406country:USjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-12-302020-06-280000200406country:USjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2018-12-312019-06-300000200406jnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2020-03-302020-06-280000200406jnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-04-012019-06-300000200406jnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2019-12-302020-06-280000200406jnj:GENERALMemberjnj:MedicalDevicesMemberjnj:SurgeryMember2018-12-312019-06-300000200406country:USjnj:VisionMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:VisionMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:VisionMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:VisionMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:VisionMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:VisionMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:VisionMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:VisionMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:VisionMemberjnj:CONTACTLENSESOTHERMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406country:USjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2020-03-302020-06-280000200406country:USjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2019-04-012019-06-300000200406country:USjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2019-12-302020-06-280000200406country:USjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2018-12-312019-06-300000200406jnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2020-03-302020-06-280000200406jnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2019-04-012019-06-300000200406jnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2019-12-302020-06-280000200406jnj:VisionMemberjnj:MedicalDevicesMemberjnj:SURGICALMember2018-12-312019-06-300000200406country:USjnj:MedicalDevicesMember2020-03-302020-06-280000200406country:USjnj:MedicalDevicesMember2019-04-012019-06-300000200406country:USjnj:MedicalDevicesMember2019-12-302020-06-280000200406country:USjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:NonUsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:NonUsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:NonUsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:NonUsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:MedicalDevicesMember2020-03-302020-06-280000200406jnj:MedicalDevicesMember2019-04-012019-06-300000200406jnj:MedicalDevicesMember2018-12-312019-06-300000200406country:US2020-03-302020-06-280000200406country:US2019-04-012019-06-300000200406country:US2019-12-302020-06-280000200406country:US2018-12-312019-06-300000200406us-gaap:NonUsMember2020-03-302020-06-280000200406us-gaap:NonUsMember2019-04-012019-06-300000200406us-gaap:NonUsMember2019-12-302020-06-280000200406us-gaap:NonUsMember2018-12-312019-06-300000200406us-gaap:OperatingSegmentsMemberjnj:ConsumerMember2020-03-302020-06-280000200406us-gaap:OperatingSegmentsMemberjnj:ConsumerMember2019-04-012019-06-300000200406us-gaap:OperatingSegmentsMemberjnj:ConsumerMember2019-12-302020-06-280000200406us-gaap:OperatingSegmentsMemberjnj:ConsumerMember2018-12-312019-06-300000200406us-gaap:OperatingSegmentsMemberjnj:PharmaceuticalMember2020-03-302020-06-280000200406us-gaap:OperatingSegmentsMemberjnj:PharmaceuticalMember2019-04-012019-06-300000200406us-gaap:OperatingSegmentsMemberjnj:PharmaceuticalMember2019-12-302020-06-280000200406us-gaap:OperatingSegmentsMemberjnj:PharmaceuticalMember2018-12-312019-06-300000200406us-gaap:OperatingSegmentsMemberjnj:MedicalDevicesMember2020-03-302020-06-280000200406us-gaap:OperatingSegmentsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406us-gaap:OperatingSegmentsMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406us-gaap:OperatingSegmentsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406us-gaap:OperatingSegmentsMember2020-03-302020-06-280000200406us-gaap:OperatingSegmentsMember2019-04-012019-06-300000200406us-gaap:OperatingSegmentsMember2019-12-302020-06-280000200406us-gaap:OperatingSegmentsMember2018-12-312019-06-300000200406us-gaap:CorporateNonSegmentMember2020-03-302020-06-280000200406us-gaap:CorporateNonSegmentMember2019-04-012019-06-300000200406us-gaap:CorporateNonSegmentMember2019-12-302020-06-280000200406us-gaap:CorporateNonSegmentMember2018-12-312019-06-300000200406jnj:ConsumerMemberjnj:CizHoldingsCo.Ltd.Member2019-04-012019-06-300000200406us-gaap:OtherIncomeMemberjnj:MedicalDevicesMemberjnj:AurisHealthMember2019-12-302020-06-280000200406jnj:AdvancedSterilizationProductsMemberjnj:MedicalDevicesMember2018-12-312019-06-300000200406jnj:AdvancedSterilizationProductsMemberjnj:MedicalDevicesMember2019-04-012019-06-300000200406srt:EuropeMember2020-03-302020-06-280000200406srt:EuropeMember2019-04-012019-06-300000200406srt:EuropeMember2019-12-302020-06-280000200406srt:EuropeMember2018-12-312019-06-300000200406jnj:WesternHemisphereExcludingUSMember2020-03-302020-06-280000200406jnj:WesternHemisphereExcludingUSMember2019-04-012019-06-300000200406jnj:WesternHemisphereExcludingUSMember2019-12-302020-06-280000200406jnj:WesternHemisphereExcludingUSMember2018-12-312019-06-300000200406jnj:AsiaPacificAfricaMember2020-03-302020-06-280000200406jnj:AsiaPacificAfricaMember2019-04-012019-06-300000200406jnj:AsiaPacificAfricaMember2019-12-302020-06-280000200406jnj:AsiaPacificAfricaMember2018-12-312019-06-300000200406jnj:IdorsiaLTDMemberus-gaap:SubsequentEventMember2020-07-092020-07-09iso4217:CHFiso4217:CHFxbrli:shares0000200406jnj:IdorsiaLTDMemberus-gaap:SubsequentEventMember2020-07-090000200406jnj:IdorsiaLTDMemberus-gaap:ConvertibleDebtMemberjnj:IdorsiaLTDMember2020-06-280000200406jnj:IdorsiaLTDMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberjnj:IdorsiaLTDMember2020-06-280000200406jnj:BermekimabMember2020-03-302020-06-280000200406jnj:BermekimabMember2020-06-280000200406jnj:VerbSurgicalInc.Member2020-06-280000200406jnj:AdvancedSterilizationProductsMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2019-04-010000200406jnj:AdvancedSterilizationProductsMember2019-04-012019-04-010000200406jnj:AurisHealthMember2019-04-012019-04-010000200406jnj:AurisHealthMember2019-04-010000200406us-gaap:OtherIncomeMemberjnj:AurisHealthMember2020-03-302020-06-280000200406jnj:AurisHealthMember2020-06-28iso4217:JPY0000200406jnj:CizHoldingsCo.Ltd.Member2019-01-172019-01-170000200406jnj:CizHoldingsCo.Ltd.Member2019-01-160000200406jnj:CizHoldingsCo.Ltd.Member2019-04-012019-06-300000200406jnj:CizHoldingsCo.Ltd.Member2020-06-280000200406jnj:CizHoldingsCo.Ltd.Member2019-12-302020-06-280000200406us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberjnj:SupplyChainMember2020-06-28jnj:claimant0000200406jnj:AsrMember2020-06-280000200406jnj:PinnacleAcetabularCupSystemMember2020-06-280000200406jnj:PelvicMeshesMember2020-06-280000200406jnj:RisperdalMember2020-06-280000200406jnj:XareltoMember2020-06-280000200406jnj:TalcMember2020-06-280000200406jnj:InvokanaMember2020-06-280000200406jnj:PhysiomeshMember2020-06-28jnj:patient0000200406jnj:DePuyASRU.S.Memberus-gaap:SettledLitigationMember2020-06-280000200406us-gaap:JudicialRulingMember2019-09-302019-12-290000200406us-gaap:JudicialRulingMember2020-01-012020-01-310000200406jnj:BabyPowderMember2018-07-012018-07-310000200406jnj:BabyPowderMemberus-gaap:JudicialRulingMember2020-06-012020-06-280000200406jnj:OpioidMember2019-12-290000200406jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMemberus-gaap:JudicialRulingMember2019-12-302020-06-280000200406us-gaap:SettledLitigationMemberjnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember2019-12-302020-06-280000200406us-gaap:PendingLitigationMember2019-10-310000200406us-gaap:JudicialRulingMember2019-12-302020-06-280000200406jnj:SupplyChainMember2020-03-302020-06-280000200406us-gaap:RestructuringChargesMemberjnj:SupplyChainMember2020-03-302020-06-280000200406us-gaap:CostOfSalesMemberjnj:SupplyChainMember2020-03-302020-06-280000200406jnj:OtherIncomeExpenseNetMemberjnj:SupplyChainMember2020-03-302020-06-280000200406jnj:SupplyChainMember2019-12-302020-06-280000200406us-gaap:RestructuringChargesMemberjnj:SupplyChainMember2019-12-302020-06-280000200406us-gaap:CostOfSalesMemberjnj:SupplyChainMember2019-12-302020-06-280000200406jnj:OtherIncomeExpenseNetMemberjnj:SupplyChainMember2019-12-302020-06-280000200406jnj:SupplyChainMember2020-06-280000200406srt:MinimumMemberjnj:SupplyChainMember2020-06-280000200406srt:MaximumMemberjnj:SupplyChainMember2020-06-280000200406srt:MinimumMemberjnj:MedicalDevicesMemberjnj:SupplyChainMember2019-12-302020-06-280000200406srt:MaximumMemberjnj:MedicalDevicesMemberjnj:SupplyChainMember2019-12-302020-06-280000200406jnj:MedicalDevicesMemberus-gaap:EmployeeSeveranceMember2019-12-290000200406jnj:MedicalDevicesMemberjnj:AssetWriteoffMember2019-12-290000200406us-gaap:OtherRestructuringMemberjnj:MedicalDevicesMember2019-12-290000200406jnj:MedicalDevicesMember2019-12-290000200406jnj:MedicalDevicesMemberus-gaap:EmployeeSeveranceMember2019-12-302020-06-280000200406jnj:MedicalDevicesMemberjnj:AssetWriteoffMember2019-12-302020-06-280000200406us-gaap:OtherRestructuringMemberjnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:MedicalDevicesMember2019-12-302020-06-280000200406jnj:MedicalDevicesMemberus-gaap:EmployeeSeveranceMember2020-06-280000200406jnj:MedicalDevicesMemberjnj:AssetWriteoffMember2020-06-280000200406us-gaap:OtherRestructuringMemberjnj:MedicalDevicesMember2020-06-280000200406jnj:MedicalDevicesMember2020-06-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
   
 Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for the quarterly period ended June 28, 2020

or
   
 Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for the transition period from            to
Commission file number 1-3215
Johnson & Johnson
(Exact name of registrant as specified in its charter)
New Jersey
 22-1024240
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(Address of principal executive offices)
Registrant’s telephone number, including area code (732524-0400
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicated by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No






SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $1.00JNJNew York Stock Exchange
0.250% Notes Due January 2022JNJNew York Stock Exchange
0.650% Notes Due May 2024JNJNew York Stock Exchange
5.50% Notes Due November 2024JNJNew York Stock Exchange
1.150% Notes Due November 2028JNJNew York Stock Exchange
1.650% Notes Due May 2035JNJNew York Stock Exchange
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
On July 20, 2020, 2,632,823,475 shares of Common Stock, $1.00 par value, were outstanding.





JOHNSON & JOHNSON AND SUBSIDIARIES
TABLE OF CONTENTS
 Page
 No.
  
  
  
  
  
  
  
  
  
  
  
  
  





CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and Johnson & Johnson's other publicly available documents contain forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Management and representatives of Johnson & Johnson and its subsidiaries (the Company) also may from time to time make forward-looking statements. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates,” and other words of similar meaning in conjunction with, among other things: discussions of future operations, expected operating results, financial performance; impact of planned acquisitions and dispositions; impact and timing of restructuring initiatives including associated cost savings and other benefits; the Company's strategy for growth; product development activities; regulatory approvals; market position and expenditures.
Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company's control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company’s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements. Risks and uncertainties include, but are not limited to:
Risks Related to Product Development, Market Success and Competition
Challenges and uncertainties inherent in innovation and development of new and improved products and technologies on which the Company’s continued growth and success depend, including uncertainty of clinical outcomes, additional analysis of existing clinical data, obtaining regulatory approvals, health plan coverage and customer access, and initial and continued commercial success;
Challenges to the Company’s ability to obtain and protect adequate patent and other intellectual property rights for new and existing products and technologies in the United States and other important markets;
The impact of patent expirations, typically followed by the introduction of competing biosimilars and generics and resulting revenue and market share losses;
Increasingly aggressive and frequent challenges to the Company’s patents by competitors and others seeking to launch competing generic, biosimilar or other products and increased receptivity of courts, the United States Patent and Trademark Office and other decision makers to such challenges, potentially resulting in loss of market exclusivity and rapid decline in sales for the relevant product sooner than expected;
Competition in research and development of new and improved products, processes and technologies, which can result in product and process obsolescence;
Competition to reach agreement with third parties for collaboration, licensing, development and marketing agreements for products and technologies;
Competition based on cost-effectiveness, product performance, technological advances and patents attained by competitors; and
Allegations that the Company’s products infringe the patents and other intellectual property rights of third parties, which could adversely affect the Company’s ability to sell the products in question and require the payment of money damages and future royalties.
Risks Related to Product Liability, Litigation and Regulatory Activity
Product efficacy or safety concerns, whether or not based on scientific evidence, potentially resulting in product withdrawals, recalls, regulatory action on the part of the United States Food and Drug Administration (or international counterparts), declining sales, reputational damage, increased litigation expense and share price impact;
Impact, including declining sales and reputational damage, of significant litigation or government action adverse to the Company, including product liability claims and allegations related to pharmaceutical marketing practices and contracting strategies;
Impact of an adverse judgment or settlement and the adequacy of reserves related to legal proceedings, including patent litigation, product liability, personal injury claims, securities class actions, government investigations, employment and other legal proceedings;



Increased scrutiny of the health care industry by government agencies and state attorneys general resulting in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including, but not limited to, debarment from government business;
Failure to meet compliance obligations in the McNEIL-PPC, Inc. Consent Decree or any other compliance agreements with governments or government agencies, which could result in significant sanctions;
Potential changes to applicable laws and regulations affecting United States and international operations, including relating to: approval of new products; licensing and patent rights; sales and promotion of health care products; access to, and reimbursement and pricing for, health care products and services; environmental protection and sourcing of raw materials;
Compliance with local regulations and laws that may restrict the Company’s ability to manufacture or sell its products in relevant markets including, requirements to comply with medical device reporting regulations and other requirements such as the European Union's Medical Devices Regulation;
Changes in domestic and international tax laws and regulations, including changes related to The Tax Cuts and Jobs Act in the United States, the Federal Act on Tax Reform and AHV Financing in Switzerland, increasing audit scrutiny by tax authorities around the world and exposures to additional tax liabilities potentially in excess of existing reserves; and
Issuance of new or revised accounting standards by the Financial Accounting Standards Board and regulations by the Securities and Exchange Commission.
Risks Related to the Company’s Strategic Initiatives and Healthcare Market Trends
Pricing pressures resulting from trends toward health care cost containment, including the continued consolidation among health care providers and other market participants, trends toward managed care, the shift toward governments increasingly becoming the primary payers of health care expenses, significant new entrants to the health care markets seeking to reduce costs and government pressure on companies to voluntarily reduce costs and price increases;
Restricted spending patterns of individual, institutional and governmental purchasers of health care products and services due to economic hardship and budgetary constraints;
Challenges to the Company’s ability to realize its strategy for growth including through externally sourced innovations, such as development collaborations, strategic acquisitions, licensing and marketing agreements, and the potential heightened costs of any such external arrangements due to competitive pressures;
The potential that the expected strategic benefits and opportunities from any planned or completed acquisition or divestiture by the Company may not be realized or may take longer to realize than expected; and
The potential that the expected benefits and opportunities related to past and ongoing restructuring actions may not be realized or may take longer to realize than expected.
Risks Related to Economic Conditions, Financial Markets and Operating Internationally
The risks associated with global operations, including the impact of global public health crises and pandemics, such as the outbreak of the novel coronavirus (COVID-19), on the Company and its customers and suppliers, including foreign governments in countries in which the Company operates.
Impact of inflation and fluctuations in interest rates and currency exchange rates and the potential effect of such fluctuations on revenues, expenses and resulting margins;
Potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs and potential drug reimportation legislation;
The impact on international operations from financial instability in international economies, sovereign risk, possible imposition of governmental controls and restrictive economic policies, and unstable international governments and legal systems;
Changes to global climate, extreme weather and natural disasters that could affect demand for the Company's products and services, cause disruptions in manufacturing and distribution networks, alter the availability of goods and services within the supply chain, and affect the overall design and integrity of the Company's products and operations;
The impact of armed conflicts and terrorist attacks in the United States and other parts of the world including social and economic disruptions and instability of financial and other markets; and




Risks Related to Supply Chain and Operations
Difficulties and delays in manufacturing, internally through third party providers or otherwise within the supply chain, that may lead to voluntary or involuntary business interruptions or shutdowns, product shortages, withdrawals or suspensions of products from the market, and potential regulatory action;
Interruptions and breaches of the Company's information technology systems or those of the Company's vendors which, could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action;
Reliance on global supply chains and production and distribution processes that are complex and subject to increasing regulatory requirements that may adversely affect supply, sourcing and pricing of materials used in the Company’s products; and
The potential that the expected benefits and opportunities related to restructuring actions contemplated for the global supply chain, including the Company's transaction with Jabil Inc., may not be realized or may take longer to realize than expected, including due to any required approvals from applicable regulatory authorities. Disruptions associated with the announced global supply chain actions may adversely affect supply and sourcing of materials used in the Company's products.
Investors also should carefully read the Risk Factors described in Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 29, 2019, for a description of certain risks that could, among other things, cause the Company’s actual results to differ materially from those expressed in its forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.


Table of Contents
Part I — FINANCIAL INFORMATION

Item 1 — FINANCIAL STATEMENTS

JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited; Dollars in Millions Except Share and Per Share Data)
June 28, 2020December 29, 2019
ASSETS
Current assets:  
Cash and cash equivalents$11,174  17,305  
Marketable securities7,961  1,982  
Accounts receivable, trade, less allowances for doubtful accounts and credit losses $334 (2019, $226)14,645  14,481  
Inventories (Note 2)9,424  9,020  
Prepaid expenses and other2,588  2,392  
Assets held for sale (Note 10)100  94  
Total current assets45,892  45,274  
Property, plant and equipment at cost44,056  43,332  
Less: accumulated depreciation(26,458) (25,674) 
Property, plant and equipment, net17,598  17,658  
Intangible assets, net (Note 3)47,413  47,643  
Goodwill (Note 3)33,890  33,639  
Deferred taxes on income (Note 5)7,805  7,819  
Other assets5,782  5,695  
Total assets$158,380  157,728  
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:  
Loans and notes payable$5,332  1,202  
Accounts payable6,765  8,544  
Accrued liabilities8,940  9,715  
Accrued rebates, returns and promotions11,790  10,883  
Accrued compensation and employee related obligations2,313  3,354  
Accrued taxes on income (Note 5)1,632  2,266  
Total current liabilities36,772  35,964  
Long-term debt (Note 4)25,062  26,494  
Deferred taxes on income (Note 5)
5,532  5,958  
Employee related obligations (Note 6)10,411  10,663  
Long-term taxes payable (Note 5)6,591  7,444  
Other liabilities11,034  11,734  
Total liabilities95,402  98,257  
Commitments and Contingencies (Note 11)
Shareholders’ equity:  
Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)$3,120  3,120  
Accumulated other comprehensive income (loss) (Note 7)(15,533) (15,891) 
Retained earnings113,898  110,659  
Less: common stock held in treasury, at cost (487,466,000 and 487,336,000 shares)38,507  38,417  
Total shareholders’ equity62,978  59,471  
Total liabilities and shareholders' equity$158,380  157,728  
See Notes to Consolidated Financial Statements
1

Table of Contents
JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited; Dollars & Shares in Millions Except Per Share Amounts)
 Fiscal Second Quarter Ended
June 28,
2020
Percent
to Sales
June 30,
2019
Percent
to Sales
Sales to customers (Note 9)$18,336  100.0 %$20,562  100.0 %
Cost of products sold6,579  35.9  6,940  33.8  
Gross profit11,757  64.1  13,622  66.2  
Selling, marketing and administrative expenses4,993  27.2  5,546  27.0  
Research and development expense2,707  14.8  2,666  13.0  
In-process research and development6  0.0      
Interest income(19) (0.1) (88) (0.4) 
Interest expense, net of portion capitalized45  0.3  83  0.4  
Other (income) expense, net24  0.1  (1,683) (8.2) 
Restructuring (Note 12)61  0.3  57  0.2  
Earnings before provision for taxes on income3,940  21.5  7,041  34.2  
Provision for taxes on income (Note 5)314  1.7  1,434  6.9  
NET EARNINGS $3,626  19.8 %$5,607  27.3 %
NET EARNINGS PER SHARE (Note 8)    
Basic$1.38   $2.11   
Diluted$1.36   $2.08   
AVG. SHARES OUTSTANDING    
Basic2,632.9   2,652.5   
Diluted2,665.5   2,691.7   


See Notes to Consolidated Financial Statements


2

Table of Contents
JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited; Dollars & Shares in Millions Except Per Share Amounts)
Fiscal Six Months Ended
June 28,
2020
Percent
to Sales
June 30,
2019
Percent
to Sales
Sales to customers (Note 9)$39,027  100.0 %$40,583  100.0 %
Cost of products sold13,641  35.0